Helen Marr

Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia

Philip Law, Sonja I. Berndt, Helen E. Speedy et al. · Nature Communications · 2017 · 104 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post‐<scp>BCR</scp>inhibitor setting: a<scp>UK</scp>wide analysis

Toby A. Eyre, Amy A. Kirkwood, George Follows et al. · British Journal of Haematology · 2019 · 79 citations · Full text

Medicine, Hematology, Pharmacotherapy +15

Inhibition of ATR acutely sensitizes acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductase

Sarah Fordham, Helen J. Blair, Claire Elstob et al. · Blood Advances · 2018 · 46 citations · Full text

Medicine, Oncology, Pharmacology +9

Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy

Yusri Taha, Hayley Wardle, Adam B. Evans et al. · Annals of Clinical Microbiology and Antimicrobials · 2021 · 38 citations · Full text

Life Sciences, Immunology, Infectious Diseases +12

Non-genotoxic MDM2 inhibition selectively induces a pro-apoptotic p53 gene signature in chronic lymphocytic leukemia cells

Carmela Ciardullo, Erhan Aptullahoğlu, Laura Woodhouse et al. · Haematologica · 2019 · 29 citations · Full text

Medicine, Oncology, Pharmacology +16